Literature DB >> 30513362

Increased susceptibility to develop spontaneous and post-traumatic osteoarthritis in Dot1l-deficient mice.

F M F Cornelis1, A de Roover2, L Storms3, A Hens4, R J Lories5, S Monteagudo6.   

Abstract

OBJECTIVE: We earlier identified that the histone methyltransferase Disruptor of telomeric silencing 1-like (DOT1L) is as a master protector of cartilage health via limiting excessive activation of the Wnt pathway. However, cartilage-specific homozygous Dot1l knockout mice exhibited a severe growth phenotype and perinatal death, which hampered their use in induced or ageing models of osteoarthritis (OA). The aim of this study was to generate and examine haploinsufficient and inducible conditional Dot1l-deficient mouse models to evaluate the importance of DOT1L during post-traumatic or ageing-associated OA onset and progression.
METHOD: We used cartilage-specific heterozygous and postnatal tamoxifen-inducible Dot1l knockout mice and performed destabilization of the medial meniscus (DMM) and ageing as OA models. Mice were examined histologically using X-rays and micro-computed tomography (μCT), and cartilage damage and osteophyte formation were assessed based on OARSI guidelines. Immunohistochemistry of DOT1L, H3K79me2, TCF1 and COLX was performed.
RESULTS: Both Dot1l-deficient strains exhibit a phenotype characterized by joint remodeling with extensive osteophyte formation and ectopic ossification upon ageing, indicating accelerated development of spontaneous osteoarthritis. In the DMM-induced OA mouse model, absence of Dot1l resulted in increased cartilage damage. Wnt signalling hyper-activation and ectopic chondrocyte hypertrophy were observed in the articular cartilage of both Dot1l-deficient mice.
CONCLUSIONS: This study demonstrated the functional relevance of DOT1L in vivo during the development of OA using genetically modified mice. Thus, maintaining or enhancing DOT1L activity during ageing or after trauma might prevent OA onset and progression.
Copyright © 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ageing; Cartilage; DMM; DOT1L; Epigenetics; Osteoarthritis

Mesh:

Substances:

Year:  2018        PMID: 30513362     DOI: 10.1016/j.joca.2018.11.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  13 in total

Review 1.  Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis.

Authors:  Tom Hodgkinson; Domhnall C Kelly; Caroline M Curtin; Fergal J O'Brien
Journal:  Nat Rev Rheumatol       Date:  2021-12-21       Impact factor: 20.543

2.  Disorganization of chondrocyte columns in the growth plate does not aggravate experimental osteoarthritis in mice.

Authors:  Ana Lamuedra; Paula Gratal; Lucía Calatrava; Víctor Luis Ruiz-Perez; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 3.  Review Article: Is Wnt Signaling an Attractive Target for the Treatment of Osteoarthritis?

Authors:  Rik J Lories; Silvia Monteagudo
Journal:  Rheumatol Ther       Date:  2020-04-10

Review 4.  Histone Modifications and Chondrocyte Fate: Regulation and Therapeutic Implications.

Authors:  Chao Wan; Fengjie Zhang; Hanyu Yao; Haitao Li; Rocky S Tuan
Journal:  Front Cell Dev Biol       Date:  2021-04-16

Review 5.  Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models.

Authors:  Yuchen He; Zhong Li; Peter G Alexander; Brian D Ocasio-Nieves; Lauren Yocum; Hang Lin; Rocky S Tuan
Journal:  Biology (Basel)       Date:  2020-07-29

6.  The Role of Dot1l in Prenatal and Postnatal Murine Chondrocytes and Trabecular Bone.

Authors:  Stephanie Y Jo; Miriam S Domowicz; Judith G Henry; Nancy B Schwartz
Journal:  JBMR Plus       Date:  2019-12-17

7.  Maternal DOT1L is dispensable for mouse development.

Authors:  Ji Liao; Piroska E Szabó
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

8.  Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3.

Authors:  Xue Chen; Yuanyuan Shi; Pan Xue; Xinli Ma; Junfeng Li; Jun Zhang
Journal:  Arthritis Res Ther       Date:  2020-10-27       Impact factor: 5.156

9.  Hypoxia induces DOT1L in articular cartilage to protect against osteoarthritis.

Authors:  Astrid De Roover; Ana Escribano Núñez; Frederique Mf Cornelis; Chahrazad Cherifi; Leire Casas-Fraile; An Sermon; Frederic Cailotto; Rik J Lories; Silvia Monteagudo
Journal:  JCI Insight       Date:  2021-12-22

10.  Mesenchyme-specific loss of Dot1L histone methyltransferase leads to skeletal dysplasia phenotype in mice.

Authors:  Pearl A Sutter; Sangita Karki; Ilan Crawley; Vijender Singh; Kathrin M Bernt; David W Rowe; Stephen J Crocker; Dashzeveg Bayarsaihan; Rosa M Guzzo
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.